Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag during consolidation therapy in AML
NCT01656252Phase 2Terminated
- Sponsor
- PrECOG
- Start
- Jul 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in acute myeloid leukemia (AML), sponsored by PrECOG. Started Jul 2012; status: terminated.
02
Drugs
eltrombopag
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01656252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656252.